<!DOCTYPE html>
<html>
    <head>
        <title>STD Tx Guidelines</title>
    </head>
    <body>
        <!-- Start of page -->
        <div data-role="page" id="g353" data-theme="a">
            <div data-role="header" data-id="guidelines-header" data-theme="b" data-position="fixed">
                <a href="lv-351.html" class="ui-btn ui-icon-back ui-btn-icon-notext ui-corner-all" aria-label="back"></a>
                <h3>STD Tx Guidelines</h3>
	<a href="../menu.html" class="ui-btn ui-icon-grid ui-btn-icon-notext ui-corner-all" aria-label="main menu"></a>
            </div>
            <div data-role="content">
            <div id=guidelines_breadcrumbs>
            
                    <a href="lv-341.html" >Full Guidelines</a><span class="carrot"> > </span>
                    <a href="lv-351.html" >Vaccine-Preventable STDs</a><span class="carrot"> > </span>
                    <a href="lv-351.html" >Hepatitis B</a><span class="carrot"> > </span>Treatment
            </div>
            </br><h3 class="sgc-1" id="sigil_toc_id_353">
 Treatment
</h3>
<p>
 No specific therapy is available for persons with acute hepatitis B; treatment is supportive. Persons with chronic HBV infection should be referred for evaluation to a physician&nbsp;experienced in the management of CLD. Therapeutic agents cleared by FDA for treatment of chronic hepatitis B can achieve sustained suppression of HBV replication and remission of liver disease in some persons. In addition, patients with chronic hepatitis B might benefit from screening to detect HCC at an early stage.
</p>

            </div>
        </div>
        <!-- end of guidelines heading page -->
    </body>
</html>

